Pro Share Advisors LLC Sorrento Therapeutics, Inc. Transaction History

Pro Share Advisors LLC

$39.7 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 02, 2023	BUY	$0.74 - $1.83 $12,907 - $31,920	17,443 Added 41.62%	59,354 $52,000
Q3 2022 Nov 04, 2022	SELL	$1.51 - $2.88 $1,209 - $2,306	-801 Reduced 1.88%	41,911 $66,000
Q2 2022 Aug 01, 2022	SELL	$1.24 - $2.33 $16,494 - $30,993	-13,302 Reduced 23.75%	42,712 $86,000
Q1 2022 May 10, 2022	SELL	$2.0 - $4.9 $18,502 - $45,329	-9,251 Reduced 14.17%	56,014 $131,000
Q4 2021 Feb 08, 2022	BUY	$4.65 - $7.23 $137,928 - $214,456	29,662 Added 83.31%	65,265 $303,000
Q3 2021 Nov 12, 2021	SELL	$7.41 - $10.99 $260,291 - $386,045	-35,127 Reduced 49.66%	35,603 $272,000
Q2 2021 Aug 13, 2021	BUY	$6.35 - $10.0 $24,409 - $38,440	3,844 Added 5.75%	70,730 $685,000
Q1 2021 May 14, 2021	BUY	$7.03 - $16.51 $80,402 - $188,824	11,437 Added 20.63%	66,886 $553,000
Q4 2020 Feb 09, 2021	BUY	$5.76 - $11.95 $163,082 - $338,340	28,313 Added 104.34%	55,449 $378,000
Q3 2020 Nov 13, 2020	BUY	$6.17 - $18.82 $20,379 - $62,162	3,303 Added 13.86%	27,136 $303,000
Q2 2020 Aug 03, 2020	BUY	$1.73 - $6.76 $41,231 - $161,111	23,833 New	23,833 $150,000
Q1 2020 May 15, 2020	SELL	$1.57 - $4.76 $26,628 - $80,734	-16,961 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$1.45 - $4.17 $3,928 - $11,296	2,709 Added 19.01%	16,961 $57,000
Q3 2019 Nov 12, 2019	BUY	$2.05 - $2.69 $4,341 - $5,697	2,118 Added 17.46%	14,252 $30,000
Q2 2019 Aug 13, 2019	SELL	$2.67 - $4.38 $849 - $1,392	-318 Reduced 2.55%	12,134 $32,000
Q1 2019 May 15, 2019	BUY	$1.86 - $5.94 $1,737 - $5,547	934 Added 8.11%	12,452 $59,000
Q4 2018 Feb 14, 2019	SELL	$2.01 - $4.24 $3,732 - $7,873	-1,857 Reduced 13.88%	11,518 $28,000
Q3 2018 Nov 14, 2018	BUY	$4.22 - $7.5 $8,119 - $14,430	1,924 Added 16.8%	13,375 $59,000
Q2 2018 Aug 13, 2018	BUY	$4.75 - $8.0 $54,392 - $91,608	11,451 New	11,451 $82,000

Others Institutions Holding SRNE

# of Institutions

Shares Held

5.47M

Call Options Held

Put Options Held

View Full List

About Sorrento Therapeutics, Inc.

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

More about SRNE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Account